{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:20Z","timestamp":1787023640768,"version":"build-2736575974"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,3,30]]},"DOI":"10.18632\/oncotarget.3446","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T03:55:06Z","timestamp":1442289306000},"page":"6544-6552","source":"Crossref","is-referenced-by-count":36,"title":["Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth"],"prefix":"10.18632","volume":"6","author":[{"given":"Marco","family":"Pizzi","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgical Pathology and Cytopathology Unit, DIMED University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Clinical Immunology Branch, DIMED University of Padua, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[{"name":"Department of Experimental, Hematopathology and Hematology Sections, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fuligni","sequence":"additional","affiliation":[{"name":"Department of Experimental, Hematopathology and Hematology Sections, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Benvenuti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgical Pathology and Cytopathology Unit, DIMED University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mandato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Clinical Immunology Branch, DIMED University of Padua, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Casellato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Clinical Immunology Branch, DIMED University of Padua, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgical Pathology and Cytopathology Unit, DIMED University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Clinical Immunology Branch, DIMED University of Padua, Padua, Italy"},{"name":"Venetian Institute of Molecular Medicine (VIMM), Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[{"name":"Department of Experimental, Hematopathology and Hematology Sections, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,1,31]]},"reference":[{"issue":"Pt 1","key":"1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021469","article-title":"Protein kinase CK2: structure, regulation and role in cellular decisions of life and death","volume":"369","author":"Litchfield","year":"2003","journal-title":"Biochem J"},{"issue":"3","key":"2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1096\/fj.02-0473rev","article-title":"One-thousand-and-one substrates of protein kinase CK2?","volume":"17","author":"Pinna","year":"2003","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"3","key":"3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/MCB.23.3.908-915.2003","article-title":"Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality","volume":"23","author":"Boldyreff","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/MCB.01119-07","article-title":"The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development","volume":"28","author":"Seldin","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"6","key":"5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.385","article-title":"Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways","volume":"26","author":"Semenzato","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbapap.2009.07.018","article-title":"Addiction to protein kinase CK2: a common denominator of diverse cancer cells?","volume":"1804","author":"Pinna","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcb.20847","article-title":"CK2 signaling in androgen-dependent and -independent prostate cancer","volume":"99","author":"Ahmed","year":"2006","journal-title":"J Cell Biochem"},{"issue":"5","key":"8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejca.2010.11.028","article-title":"Protein kinase CK2alpha subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays","volume":"47","author":"Charpin","year":"2011","journal-title":"Eur J Cancer"},{"issue":"15","key":"9","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.18632\/oncotarget.2248","article-title":"Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells","volume":"5","author":"Benveniste","year":"2014","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-008-9812-7","article-title":"CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor","volume":"316","author":"Pandolfi","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2012.02.032","article-title":"Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells","volume":"322","author":"Drygin","year":"2012","journal-title":"Cancer Lett"},{"issue":"13","key":"12","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1158\/0008-5472.CAN-05-3758","article-title":"Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells","volume":"66","author":"Van Waes","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"13","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/sj.onc.1208397","article-title":"Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines","volume":"24","author":"Houghton","year":"2005","journal-title":"Oncogene"},{"key":"14","first-page":"787","article-title":"CX-4945, a selective and orally bioavailable inhibitor of protein kinase CK2 inhibits PI3K\/Akt, JAK-STAT and NF-kB signaling and induces apoptosis in multiple myeloma cells","volume":"116","author":"Anderes","year":"2010","journal-title":"Blood (ASH annual meeting abstracts)"},{"issue":"24","key":"15","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy","volume":"70","author":"Anderes","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"16","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood-2010-04-277947","article-title":"Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia","volume":"116","author":"Barata","year":"2010","journal-title":"Blood"},{"issue":"10","key":"17","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2013.228","article-title":"CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway","volume":"27","author":"Spurgeon","year":"2013","journal-title":"Leukemia"},{"issue":"9","key":"18","doi-asserted-by":"crossref","first-page":"e75280","DOI":"10.1371\/journal.pone.0075280","article-title":"Protein kinase CK2 inhibition down modulates the NF-kappaB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells","volume":"8","author":"Semenzato","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2005-11-013672","article-title":"Multiple myeloma cell survival relies on high activity of protein kinase CK2","volume":"108","author":"Semenzato","year":"2006","journal-title":"Blood"},{"issue":"7","key":"20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1158\/1078-0432.CCR-11-1789","article-title":"Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress-Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response","volume":"18","author":"Gurrieri","year":"2012","journal-title":"Clinical cancer research"},{"issue":"1","key":"21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Chinnaiyan","year":"2004","journal-title":"Neoplasia"},{"issue":"1","key":"22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Falini","year":"2004","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1432-1033.1995.tb20651.x","article-title":"Phosphorylation and activation of protein kinase CK2 by p34cdc2 are independent events","volume":"230","author":"Pinna","year":"1995","journal-title":"European journal of biochemistry \/ FEBS"},{"issue":"9","key":"24","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1128\/MCB.24.9.4065-4074.2004","article-title":"CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37","volume":"24","author":"Nishida","year":"2004","journal-title":"Mol Cell Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1196\/annals.1329.019","article-title":"Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target","volume":"1030","author":"Nishida","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"42","key":"26","doi-asserted-by":"crossref","first-page":"32592","DOI":"10.1074\/jbc.M001358200","article-title":"Tumor necrosis factor alpha-induced phosphorylation of RelA\/p65 on Ser529 is controlled by casein kinase II","volume":"275","author":"Baldwin","year":"2000","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Pittaluga","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semdp.2011.04.001","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"28","author":"Dalla-Favera","year":"2011","journal-title":"Seminars in diagnostic pathology"},{"issue":"1","key":"30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Inghirami","year":"2014","journal-title":"Cell reports"},{"issue":"7418","key":"31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Kohlhammer","year":"2012","journal-title":"Nature"},{"issue":"2","key":"32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/jm101251q","article-title":"Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer","volume":"54","author":"Anderes","year":"2011","journal-title":"J Med Chem"},{"issue":"3","key":"33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/biof.96","article-title":"Emergence of protein kinase CK2 as a key target in cancer therapy","volume":"36","author":"Ahmed","year":"2010","journal-title":"Biofactors"},{"key":"34","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s00018-009-9152-0","article-title":"Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery","volume":"66","author":"Miyata","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Rosenwald","year":"2004","journal-title":"Blood"},{"issue":"8","key":"36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jcp.2010.078253","article-title":"Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis","volume":"63","author":"Rugge","year":"2010","journal-title":"J Clin Pathol"},{"issue":"4","key":"37","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/1535-7163.MCT-11-0613","article-title":"CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy","volume":"11","author":"Drygin","year":"2012","journal-title":"Mol Cancer Ther"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T05:38:47Z","timestamp":1599543527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,31]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,3,30]]}},"alternative-id":["3446","25788269"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3446","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,31]]}}}